Compliance

  • April 15, 2026

    NJ Towns Urge 3rd Circ. To Revive Suit Over Housing Law

    A group of New Jersey municipalities and elected officials told the Third Circuit they have Article III standing for their tossed suit against the state government over a 2024 law that they claim unfairly forces them to rezone areas for affordable housing.

  • April 15, 2026

    UBS Must Reveal Atty Comms In Ex-Trader's $400M Libor Suit

    A Connecticut state judge has ordered UBS AG to hand some communications with its lawyers and prosecutors in U.S. and U.K. criminal cases to former trader Tom Hayes, whose $400 million lawsuit claims he was made a scapegoat to shield senior bank executives from Libor-rigging allegations.

  • April 15, 2026

    Ad Agencies Settle FTC's 'Brand Safety' Boycott Claims

    The Federal Trade Commission reached a deal on Wednesday with WPP, Publicis and Dentsu over concerns that "brand safety" standards allowed them to collude to steer ad money away from disfavored platforms.

  • April 15, 2026

    Jury Finds Live Nation Monopolized Concert Ticketing

    Live Nation and its Ticketmaster subsidiary harmed competition in the live entertainment sector by willfully monopolizing ticketing services to major concert venues and unlawfully tying artists' use of large amphitheaters to Live Nation's promotional services, a Manhattan federal jury found on Wednesday.

  • April 15, 2026

    ICE Arrest Memo Switch Looks 'Specious,' Judge Says

    A Manhattan federal judge on Wednesday revived an effort by civil rights groups to block immigration courthouse arrests, citing what he called an apparently deceptive Trump administration move to disclaim its earlier litigation position.

  • April 15, 2026

    Biopharma Co. Says Ex-Worker Used Files To Build AI Rival

    A biopharmaceutical consulting firm's ex-contractor illegally downloaded thousands of proprietary internal files and emails that he then used to launch a rival company powered by artificial intelligence, the firm claimed in a lawsuit, alleging that the former contractor violated federal trade secrets law.

  • April 15, 2026

    FCC Names New Carveouts From Router And Drone Bans

    The Federal Communications Commission is admitting that it once again may have been too hasty in putting all foreign-made routers and drones on the so-called covered list of technology deemed to be a risk to national security, and it will be carving out some exceptions.

  • April 14, 2026

    NAACP Sues Musk's XAI Over Data Center Pollution In Miss.

    The NAACP sued Elon Musk's artificial intelligence company, xAI, Tuesday in Mississippi federal court over a Memphis, Tennessee-area gas power plant powering its data center, claiming it failed to secure permits for the plant, which emits "dangerous pollutants" affecting communities with "significant Black populations."

  • April 14, 2026

    Google Sued By Rival Over 'Interrelated Web' Of Monopolies

    Google's "anticompetitive chokehold" over Android app distribution and in-app billing markets has kept Portugal-based Android app store alternative Aptoide from being able to compete with the tech giant, Aptoide alleged in a complaint filed Tuesday in California federal court challenging Google's "interrelated web" of monopolies.

  • April 14, 2026

    American Flag Seller Settles FTC's False 'Made In USA' Claims

    The Federal Trade Commission announced Tuesday that it has reached settlements with three businesses, including a company that sells American flags and other patriotic products, over claims that they falsely advertised and labeled products as "Made in the USA."

  • April 14, 2026

    2 Bills To Shield Kids From Online Harms Clear Senate Panel

    A pair of bipartisan legislative proposals to boost online safeguards for children sailed through a key U.S. Senate committee Tuesday, including a measure that would require social media platforms to display clear mental health warning labels each time a user accesses the service.

  • April 14, 2026

    Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told

    Hedge fund Armistice Capital and two of its executives exploited the COVID-19 pandemic to issue press releases that falsely inflated their controlling share in pharmaceutical company Vaxart, then dumped the shares for $250 million before the bottom fell out, investors told a California federal jury at the start of trial Tuesday.

  • April 14, 2026

    4th Circ. Revives Pharma Bid To Block Maryland's 340B Law

    A split Fourth Circuit panel on Tuesday tossed a Maryland district court's order denying a preliminary injunction to pharmaceutical manufacturers that have challenged a state law addressing drug delivery in the federal 340B discount program, pointing to its recent ruling that West Virginia's similar statute is likely preempted.

  • April 14, 2026

    Westlake Inks $67M Antitrust Deal With PVC Pipe Buyers

    Purchasers of polyvinyl chloride pipe urged an Illinois federal judge Tuesday to sign off on a proposed $67 million deal with Westlake Corp. that would put to rest allegations it and other PVC pipe producers conspired to fix prices, according to a motion filed in Illinois federal court.

  • April 14, 2026

    AI Security Co. Investors Seek 1st OK For $15M Settlement

    Investors in Evolv Technologies Holdings Inc. seek an initial nod for a $15 million deal to settle proposed class action claims that the company overstated the effectiveness of its flagship artificial intelligence-powered weapon detection service and improperly recognized millions in revenue from unpaid trial deals with customers.

  • April 14, 2026

    States Denied Time For Talks To Settle Drug Price-Fixing Suit

    A Connecticut federal judge Tuesday denied a request by dozens of U.S. states to freeze their antitrust case against generic-drug manufacturers, a pause the states argued would allow the parties to focus on settlement talks rather than pending discovery and motion deadlines.

  • April 14, 2026

    Justices Told That Eli Lilly's FCA Qui Tam Challenge Too Late

    A whistleblower who secured a $183 million trial win against Eli Lilly urged the U.S. Supreme Court on Tuesday to reject its constitutional challenge over his ability to sue for the federal government, arguing the drugmaker's arguments came too late.

  • April 14, 2026

    Turkey Cos. Denied Response To DOJ Price-Fix Intervention

    An Illinois federal judge refused Friday to let Agri Stats, Tyson Foods and other turkey producers respond to the Justice Department statement of interest weighing in on private price-fixing litigation against them, finding "no need" when the court is already obligated to consider the legal precedent the agency raised.

  • April 14, 2026

    Virginia Latest State To Ban Precise Location Data Sales

    Virginia has become the third state to ban the sale of consumers' precise geolocation data, following the governor's signature on Monday of legislation that received overwhelming backing from lawmakers and consumer advocates, and backlash from the advertising industry. 

  • April 14, 2026

    Ex-CFTC Chair Departs Willkie, Law Practice For Fintech Work

    The former leader of the nation's derivatives regulator dubbed "Crypto Dad" says he's leaving his law practice at Willkie Farr & Gallagher LLP to focus on advising fintechs and crypto firms, researching public policy issues and working with nonprofit programs.

  • April 14, 2026

    SEC Greenlights Rule Lifting Day Trader Equity Requirement

    The U.S. Securities and Exchange Commission on Tuesday approved eliminating a requirement that active day traders maintain a minimum amount of money in their accounts, with the Financial Industry Regulatory Authority saying the changes to its rules will give retail investors a greater chance to participate in the markets.

  • April 14, 2026

    Pomerantz To Lead Chinese Logistics Co. Investor Suit

    Attorneys from Pomerantz LLP will lead a proposed class action alleging the share prices of China-based Jayud Global Logistics Ltd. were artificially inflated through fake social media posts hyping the company before suddenly collapsing by 95% in one day.

  • April 14, 2026

    Apple Users Slam 'Distorted' Antitrust Depo Sanctions Bid

    Phone users who accuse Google of suppressing rival search engines with anticompetitive deals slammed Apple's bid for sanctions over their counsel's allegedly "unrelenting and increasingly egregious" subpoena efforts, telling a California federal judge that the tech company's motion is based on a "distorted account of the discovery record."

  • April 14, 2026

    Trump's Fed Chair Pick Will Get Senate Hearing Next Week

    The Senate Banking Committee will meet next week to vet Kevin Warsh as President Donald Trump's nominee as the next leader of the Federal Reserve, moving forward with his confirmation process despite bipartisan protests over a still-pending probe of current Fed Chair Jerome Powell.

  • April 14, 2026

    Trade Group Latest To Sue Wash. Over 340B Drug Pricing Law

    Pharmaceutical Research and Manufacturers of America claims a new Washington state law attempts to illegally reshape the federal 340B Drug Pricing Program and singles out participating drugmakers with burdensome regulations, according to a fresh federal lawsuit that follows similar constitutional challenges mounted by Novartis and AbbVie.

Expert Analysis

  • Regulators' Basel Pitch May Bring Banks Capital Relief

    Author Photo

    The prudential banking agencies' new proposals to implement the so-called Basel III endgame rules — which would modify the approach to risk-based capital, among other notable changes — represent a fundamental directional shift in bank capital requirements aimed at increasing lending capacity, says Chen Xu at Debevoise.

  • How SEC And CFTC Are Attempting To End Their 'Turf War'

    Author Photo

    Through coordinated examinations and a shared aim to end duplicative regulation, the U.S. Securities and Exchange Commission and the U.S. Commodity Futures Trading Commission's recent memorandum of understanding could represent a significant shift in the regulatory landscape for market participants subject to the jurisdiction of both agencies, say attorneys at Jenner.

  • What's Missing From Latest Gov't Claims Against Harvard

    Author Photo

    The most interesting thing about the Trump administration’s recent civil rights enforcement efforts targeting Harvard University is its decision not to assert violations of the False Claims Act when given the opportunity, despite signals that its enforcement efforts will include use of the federal FCA, say attorneys at Bass Berry.

  • How Cos. Can Prepare For 'Made In America' Ad Scrutiny

    Author Photo

    The Trump administration's executive order to combat fraudulent "Made in America" claims in consumer-facing advertising, along with actions by the Federal Trade Commission, suggest a potential increased focus on consumer protection and pricing-related matters, say attorneys at Skadden.

  • Preparing For New Calif. Pay Data Reporting Requirements

    Author Photo

    California's S.B. 464 overhauls the state's pay data reporting framework by requiring employers to use job categories that are based on the Standard Occupational Classification system, increasing both the potential visibility of pay disparities and the complexity of compliance, say attorneys at Kaufman Dolowich.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.

  • Why Indicia Of Fraud Matter In Forensic Accountant Testimony

    Author Photo

    Amid federal probes into Minnesota social welfare programs and an elevated focus on detecting and prosecuting fraud, counsel must understand the professional and procedural lines that forensic accounting experts should not cross when analyzing evidence for indicia of fraud, say Kelly Bossard and George Saitta at FTI Consulting.

  • How Cos. Can Navigate The Patchwork Of AI Safety Bills

    Author Photo

    In the first few months of 2026, state and federal lawmakers introduced hundreds of bills to address the perceived safety risks of artificial intelligence, so companies should assess whether existing or planned services could be scoped into AI safety legislation across jurisdictions, say attorneys at Hogan Lovells.

  • Unpacking FCC's Proposed Rules For Offshore Call Centers

    Author Photo

    The Federal Communications Commission recently proposed rules that would restrict the use of offshore customer service operations, citing consumer frustration, data security risks and fraud as core reasons for the sweeping regulatory move, say attorneys at Eversheds Sutherland.

  • Series

    Calif. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    As usual, California remained a hub for financial services activity in the first quarter of 2026, with key developments including the California Department of Financial Protection and Innovation's eye on consumer issues, a bill targeting "pig butchering" schemes, and jam-packed courts, say attorneys at Joseph Cohen.

  • Unused Nuke Licenses Offer Shortcut For New Reactor Builds

    Author Photo

    While much has been done to accelerate the deployment of new nuclear generation, a number of still-valid licenses issued by the Nuclear Regulatory Commission for reactors that have not yet been built represent an unutilized resource for project developers looking to start construction quickly, say attorneys at K&L Gates.

  • Series

    Ultramarathons Make Me A Better Lawyer

    Author Photo

    Completing a 100-mile ultramarathon was tougher, more humbling and more rewarding than I ever imagined, and the experience highlighted how long-distance running has sharpened my ability to adapt to the evolving nature of antitrust law and strengthened my resolve to handle demanding, unforeseen challenges, says Dan Oakes at Axinn.

  • When AI Puffery Becomes Actionable Securities Fraud

    Author Photo

    Though courts usually hold that vague but optimistic corporate statements don’t constitute securities fraud, signs suggest that investors may give enough economic weight to references to artificial intelligence in public company disclosures that broad feel-good statements could cross into actionable misrepresentation, says Christine Polek at Keystone Strategy.

  • Key Takeaways From The 2026 ABA Antitrust Spring Meeting

    Author Photo

    Last week's American Bar Association Spring Meeting revealed an antitrust landscape defined by heightened friction and tension — between federal and state enforcers, domestic and international regimes, competing political visions, and traditional enforcement tools and novel challenges, say attorneys at Skadden.

  • State FARA Laws Pose Unique Constitutional Challenges

    Author Photo

    Several states have recently enacted foreign agent registration and disclosure regimes that were modeled after the Foreign Agents Registration Act, but these state laws raise several constitutional questions, including concerns about preemption, speech and petition, and vagueness, says Alexandra Langton at Covington.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.